ALUME BIOSCIENCES
Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertent injury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.
ALUME BIOSCIENCES
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.alumebiosciences.com
Total Employee:
1+
Status:
Active
Total Funding:
27.67 M USD
Technology used in webpage:
Domain Not Resolving Content Delivery Network Mobile Non Scaleable Content ReCAPTCHA JsDelivr Common Name Invalid BootstrapCDN Gravity Forms Invalid Certificate Dates Akismet
Similar Organizations
Abilita Bio
Abilita Bio Inc. is a biotechnology company.
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
2020-02-01
Current Employees Featured
James R. Schmidt Chief Financial Officer @ Alume Biosciences
Chief Financial Officer
2018-03-01
Daniel M. Bradbury Director @ Alume Biosciences
Director
2020-05-01
Quyen Nguyen Founder and CEO @ Alume Biosciences
Founder and CEO
2017-01-01
Founder
Investors List
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Alume Biosciences
Daniel M. Bradbury
Daniel M. Bradbury investment in Series A - Alume Biosciences
Chrysa Mineo
Chrysa Mineo investment in Series A - Alume Biosciences
Official Site Inspections
http://www.alumebiosciences.com
- Host name: host.touchgrove.com
- IP address: 209.59.166.76
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Alume Biosciences"
Alume Biosciences – Precision Surgery. Illuminating …
Dr. Quyen Nguyen, a surgeon-scientist at the University of California at San Diego, collaborated with Nobel Laureate Dr. Roger Tsien to develop our compound, which makes nerves glow during surgery.See details»
Alume Biosciences - Crunchbase Company Profile
Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves …See details»
ALUME BIOSCIENCES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALUME BIOSCIENCES, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Alume Biosciences - LinkedIn
The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery ...See details»
Alume Biosciences, Inc.: Drug pipelines, Patents, Clinical trials
Jul 27, 2023 Explore Alume Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 7 news, Disease Domain:Nervous System Diseases ...See details»
Alume Biosciences Management Team | Org Chart - RocketReach
Alume Biosciences employs 3 employees. The Alume Biosciences management team includes Dan Harvey (Vice President of Operations), Quyen Nguyen (Founder and Chief Executive …See details»
Alume Biosciences: Contact Details and Business Profile
The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit.See details»
Alume Biosciences - Craft
Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use. Its first product, ALM-488, is a fluorescently labeled peptide-dye …See details»
Alume Biosciences - Org Chart, Teams, Culture & Jobs - The Org
View Alume Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Alume Biosciences - PitchBook
Alume Biosciences General Information Description. Developer of a nerve illumination technology designed to help doctors perform precision surgery. The company's technology illuminates …See details»
Alume Biosciences Company Profile -Sales, Contacts, Competitors …
Alume Biosciences is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
Kim Kamdar, PhD – Alume Biosciences
Kim Kamdar Board Member Kim joined the Alume Biosciences Board of Directors in 2020. With a background in small molecule drug discovery, Kim has been involved in cutting-edge …See details»
Alume Biosciences Email Format | alumebiosciences.com Emails
The most common Alume Biosciences email format is [first].[last] (ex. jane.doe@alumebiosciences.com), which is being used by 64.6% of Alume Biosciences work …See details»
Rick Gonzales – Alume Biosciences
Rick Gonzales Chief Commercial Officer Mr. Rick Gonzalez is a seasoned executive in the life sciences industry, with over 30 years of global commercial and operational experience. He has …See details»
Alume Biosciences Granted FDA Fast Track Designation Of ALM …
LA JOLLA, Calif., May 12, 2021 /PRNewswire/ -- Alume Biosciences, Inc., a clinical stage biotechnology company developing nerve-targeted pharmaceuticals for surgical and …See details»
Alume Biosciences Announces First Patient Dosed with ALM-488 …
Aug 23, 2022 ALM-488 is a peptide-dye conjugate designed to fluorescently highlight nerves in real time during surgery. LA JOLLA, Calif., Aug. 23, 2022 /PRNewswire/ -- Alume Biosciences, …See details»
Michael Whitney, PhD – Alume Biosciences
Michael Whitney, PhD Scientific Co-Founder Vice President, Discovery Michael Whitney has over 20 years of experience in small molecule and biological drug discovery using fluorescence …See details»
Invest In Alume Biosciences Stock | Buy Pre-IPO Shares - EquityZen
Jan 11, 2023 Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a …See details»
News – Alume Biosciences
2020 Alume Biosciences Completes $5.5M Series A Financing: Robust Angel Investor-led Series A expected to fully fund Phase 1/2 clinical study for lead surgical nerve-targeting candidate, …See details»